Cowen Inc’s Corbus Pharmaceuticals CRBP Stock Holding History

Cowen Inc’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$3K	Sell	480 -1,517	-76%	-$325K	﹤0.01%	430
2019 Q1	$2K	Buy	+1,997	New	+$440K	﹤0.01%	368

Other funds holding CRBP

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cowen Inc's CRBP Position: Q2 2019 in Review

Cowen Inc sold out of Corbus Pharmaceuticals (CRBP) in Q2 2019, closing a stake of 1,483 shares — an estimated $318K sold.

Cowen Inc first reported a position in CRBP in Q4 2018 and held it in 2 quarters. The position peaked at $309K in Q1 2019. 103 funds tracked by Wall St. Rank hold CRBP as of Q2 2019.

Cowen Inc reported no remaining Corbus Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Cowen Inc sold 1,483 Corbus Pharmaceuticals shares in Q2 2019, an estimated $318K.
Cowen Inc first reported a position in Corbus Pharmaceuticals in Q4 2018 and held it in 2 quarters.
Cowen Inc's Corbus Pharmaceuticals position peaked at $309K in Q1 2019.
103 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.